95 related articles for article (PubMed ID: 9703941)
1. In vitro toxicity of A 3'-azido-3'-deoxythymidine and hydroxyurea combination on normal myeloid progenitors.
Lerza R; Castello G; Ballarino P; Mela GS; Tredici S; Arboscello E; Mencoboni M; Pannacciulli I
Anticancer Res; 1998; 18(4A):2755-8. PubMed ID: 9703941
[TBL] [Abstract][Full Text] [Related]
2. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.
Bhalla K; Birkhofer M; Grant S; Graham G
Exp Hematol; 1989 Jan; 17(1):17-20. PubMed ID: 2783247
[TBL] [Abstract][Full Text] [Related]
3. The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors.
Grillon C; Bonnet D; Mary JY; Lenfant M; Najman A; Guigon M
Stem Cells; 1993 Sep; 11(5):455-64. PubMed ID: 8241956
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS
Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163
[TBL] [Abstract][Full Text] [Related]
5. Hemotoxic effects on mice of combined administration of azidothymidine and acyclovir.
Bogliolo G; Lerza R; Mencoboni M; Flego G; Gasparini L; Pannacciulli I
Exp Hematol; 1991 Sep; 19(8):838-41. PubMed ID: 1868898
[TBL] [Abstract][Full Text] [Related]
6. In vitro synergistic inhibition of human bone marrow hemopoietic progenitor growth by a 3'-azido-3'-deoxy-thymidine, 2',3'-dideoxycytidine combination.
Lerza R; Castello G; Mela GS; Arboscello E; Cerruti A; Bogliolo G; Mencoboni M; Ballarino P; Pannacciulli I
Exp Hematol; 1997 Mar; 25(3):252-5. PubMed ID: 9091302
[TBL] [Abstract][Full Text] [Related]
7. Differential toxicity of carbovir and AZT to human bone marrow hematopoietic progenitor cells in vitro.
Kurtzberg J; Carter SG
Exp Hematol; 1990 Nov; 18(10):1094-6. PubMed ID: 2209763
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea enhances 3'-azido-3'-deoxythymidine (AZT) cytotoxicity in human chronic myeloid leukemia models.
Tosi P; Visani G; Ottaviani E; Tura S; Darnowski JW
Eur J Haematol; 1994 May; 52(5):291-5. PubMed ID: 8020629
[TBL] [Abstract][Full Text] [Related]
9. Myelotoxicity of rifabutin and 3'-azido-3'-deoxythymidine, alone and in combination, to human hematopoietic progenitor cells in vitro.
Volpe DA; Du DL; Verhoef V; Murphy MJ
Pathobiology; 1993; 61(2):77-82. PubMed ID: 8216829
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice.
Prakash O; Rodriguez VE; Tang ZY; Zhou P; Coleman R; Dhillon G; Shellito JE; Nelson S
Alcohol Clin Exp Res; 2001 Mar; 25(3):450-6. PubMed ID: 11290858
[TBL] [Abstract][Full Text] [Related]
11. Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF.
Castello G; Mela G; Cerruti A; Mencoboni M; Lerza R
Exp Hematol; 1995 Dec; 23(13):1367-71. PubMed ID: 7498365
[TBL] [Abstract][Full Text] [Related]
12. Role of human serum and cellular factors on the growth of peripheral blood CFU-gm.
Bellone G; Lista P; Veglia F; Pegoraro L; Lista L
Int J Cell Cloning; 1987 Nov; 5(6):463-71. PubMed ID: 3429932
[TBL] [Abstract][Full Text] [Related]
13. Synergistic bone marrow toxicity of pyrimethamine and zidovudine in murine in vivo and in vitro models: mechanism of toxicity.
Freund YR; Dabbs J; Creek MR; Phillips SJ; Tyson CA; MacGregor JT
Toxicol Appl Pharmacol; 2002 May; 181(1):16-26. PubMed ID: 12030838
[TBL] [Abstract][Full Text] [Related]
14. Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells.
Berman E; Duigou-Osterndorf R; Krown SE; Fanucchi MP; Chou J; Hirsch MS; Clarkson BD; Chou TC
Blood; 1989 Sep; 74(4):1281-6. PubMed ID: 2765664
[TBL] [Abstract][Full Text] [Related]
15. Increased therapeutic efficacy of zidovudine in combination with vitamin E.
Gogu SR; Beckman BS; Rangan SR; Agrawal KC
Biochem Biophys Res Commun; 1989 Nov; 165(1):401-7. PubMed ID: 2590237
[TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements.
Gillespie D; Hubbell HR; Carter WA; Midgette P; Elsasser W; Mullaney R; Strayer DR
In Vivo; 1994; 8(3):375-81. PubMed ID: 7803722
[TBL] [Abstract][Full Text] [Related]
17. Selective protection of toxicity of 2',3'-dideoxypyrimidine nucleoside analogs by beta-D-uridine in human granulocyte-macrophage progenitor cells.
Faraj A; Schinazi RF; Xie MY; Gosselin G; Perigaud C; Imbach JL; Sommadossi JP
Antiviral Res; 1996 Mar; 29(2-3):261-7. PubMed ID: 8739604
[TBL] [Abstract][Full Text] [Related]
18. Protection of 3'-azido-3'-deoxythymidine induced toxicity to murine hematopoietic progenitors (CFU-GM, BFU-E and CFU-MEG) with interleukin-1.
Gallicchio VS; Doukas MA; Hulette BC; Hughes NK; Gass C
Proc Soc Exp Biol Med; 1989 Nov; 192(2):201-4. PubMed ID: 2813453
[TBL] [Abstract][Full Text] [Related]
19. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 2003; 51(1):61-7. PubMed ID: 12691305
[TBL] [Abstract][Full Text] [Related]
20. In vitro toxicity of trichothecenes on human haematopoietic progenitors.
Parent-Massin D; Fuselier R; Thouvenot D
Food Addit Contam; 1994; 11(4):441-7. PubMed ID: 7958114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
